Mylan buyout of Perrigo heads for EU approval
Mylan is set to receive unconditional EU approval to buy rival generic drugmaker Perrigo, MLex has learned. The European Commission has until next Wednesday, July 29, to rule on the transaction.Mylan...To view the full article, register now.
Already a subscriber? Click here to view full article